Delayed onset Bickerstaff brainstem encephalitis overlapping Miller-Fisher Syndrome during SARS-CoV-2 infection
Abstract Bickerstaff brainstem encephalitis (BBE) is a neuroimmunologic disease characterized by the acute onset of external ophthalmoplegia, ataxia, and consciousness disturbance, mostly subsequent to an infection. BBE is considered to be a variant of Miller-Fisher syndrome (MFS), which also exhibits external ophthalmoplegia and ataxia but not presenting consciousness alterations. Therefore, these two medical conditions are included in the clinical spectrum of the “Fisher-Bickerstaff syndrome” ( Shahrizaila and Yuki in J Neurol Neurosurg Psychiatry 84(5):576–583) [1]. With regard to the etiopathogenesis, increasing evidence worldwide suggests that SARS-CoV-2 infection-enhanced immune response is involved in a wide range of neurological complications such as Guillain-Barré syndrome (GBS), MFS, acute necrotizing encephalitis (ANE), myelitis, acute disseminated encephalomyelitis (ADEM), and, although very rarely, BBE either (Hosseini et al. in Rev Neurosci 32:671–691) [2]. We report a case of a patient affected by delayed onset BBE overlapping MFS during a mild SARS-CoV-2 infection. To the best of our knowledge, similar cases have never been reported..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Neurological sciences - 44(2023), 12 vom: 27. Okt., Seite 4179-4182 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Acampora, R. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
|---|
| Anmerkungen: |
© Fondazione Società Italiana di Neurologia 2023 |
|---|
| doi: |
10.1007/s10072-023-07142-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR05371279X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR05371279X | ||
| 003 | DE-627 | ||
| 005 | 20231113064604.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231113s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10072-023-07142-8 |2 doi | |
| 035 | |a (DE-627)SPR05371279X | ||
| 035 | |a (SPR)s10072-023-07142-8-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Acampora, R. |e verfasserin |0 (orcid)0000-0002-9617-2821 |4 aut | |
| 245 | 1 | 0 | |a Delayed onset Bickerstaff brainstem encephalitis overlapping Miller-Fisher Syndrome during SARS-CoV-2 infection |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Fondazione Società Italiana di Neurologia 2023 | ||
| 520 | |a Abstract Bickerstaff brainstem encephalitis (BBE) is a neuroimmunologic disease characterized by the acute onset of external ophthalmoplegia, ataxia, and consciousness disturbance, mostly subsequent to an infection. BBE is considered to be a variant of Miller-Fisher syndrome (MFS), which also exhibits external ophthalmoplegia and ataxia but not presenting consciousness alterations. Therefore, these two medical conditions are included in the clinical spectrum of the “Fisher-Bickerstaff syndrome” ( Shahrizaila and Yuki in J Neurol Neurosurg Psychiatry 84(5):576–583) [1]. With regard to the etiopathogenesis, increasing evidence worldwide suggests that SARS-CoV-2 infection-enhanced immune response is involved in a wide range of neurological complications such as Guillain-Barré syndrome (GBS), MFS, acute necrotizing encephalitis (ANE), myelitis, acute disseminated encephalomyelitis (ADEM), and, although very rarely, BBE either (Hosseini et al. in Rev Neurosci 32:671–691) [2]. We report a case of a patient affected by delayed onset BBE overlapping MFS during a mild SARS-CoV-2 infection. To the best of our knowledge, similar cases have never been reported. | ||
| 650 | 4 | |a MFS |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a BBE |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a COVID-19 |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a de Falco, A. |4 aut | |
| 700 | 1 | |a Lanfranchi, F. |4 aut | |
| 700 | 1 | |a Montella, S. |4 aut | |
| 700 | 1 | |a Scala, R. |4 aut | |
| 700 | 1 | |a Lieto, M. |4 aut | |
| 700 | 1 | |a Durante, L. |4 aut | |
| 700 | 1 | |a Bruno, R. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurological sciences |d Milano : Springer, 2000 |g 44(2023), 12 vom: 27. Okt., Seite 4179-4182 |w (DE-627)SPR008581010 |w (DE-600)1481772-X |x 1590-3478 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2023 |g number:12 |g day:27 |g month:10 |g pages:4179-4182 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10072-023-07142-8 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2023 |e 12 |b 27 |c 10 |h 4179-4182 | ||